Annual Accounts Receivable
$62.41 M
-$4.87 M-7.24%
March 31, 2024
Summary
- As of February 8, 2025, LSB annual accounts receivable is $62.41 million, with the most recent change of -$4.87 million (-7.24%) on March 31, 2024.
- During the last 3 years, LSB annual accounts receivable has risen by +$29.82 million (+91.52%).
- LSB annual accounts receivable is now -7.24% below its all-time high of $67.29 million, reached on March 31, 2023.
Performance
LSB Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$75.51 M
+$16.66 M+28.31%
September 1, 2024
Summary
- As of February 8, 2025, LSB quarterly accounts receivable is $75.51 million, with the most recent change of +$16.66 million (+28.31%) on September 1, 2024.
- Over the past year, LSB quarterly accounts receivable has stayed the same.
- LSB quarterly accounts receivable is now at all-time high.
Performance
LSB Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
LSB Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.2% | 0.0% |
| 3 y3 years | +91.5% | 0.0% |
| 5 y5 years | +91.5% | 0.0% |
LSB Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.2% | +91.5% | at high | +55.6% |
| 5 y | 5-year | -7.2% | +91.5% | at high | +55.6% |
| alltime | all time | -7.2% | +91.5% | at high | +55.6% |
LakeShore Biopharma Co Ltd Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $75.51 M(+28.3%) |
| Mar 2024 | $62.41 M(-7.2%) | - |
| Sep 2023 | - | $58.85 M(-13.9%) |
| Jun 2023 | - | $68.37 M |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | $67.29 M(+38.6%) | - |
| Sep 2022 | - | $65.73 M(+35.4%) |
| Mar 2022 | $48.53 M(+48.9%) | $48.53 M |
| Mar 2021 | $32.59 M | - |
FAQ
- What is LakeShore Biopharma Co Ltd annual accounts receivable?
- What is the all time high annual accounts receivable for LakeShore Biopharma Co Ltd?
- What is LakeShore Biopharma Co Ltd annual accounts receivable year-on-year change?
- What is LakeShore Biopharma Co Ltd quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for LakeShore Biopharma Co Ltd?
- What is LakeShore Biopharma Co Ltd quarterly accounts receivable year-on-year change?
What is LakeShore Biopharma Co Ltd annual accounts receivable?
The current annual accounts receivable of LSB is $62.41 M
What is the all time high annual accounts receivable for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high annual accounts receivable is $67.29 M
What is LakeShore Biopharma Co Ltd annual accounts receivable year-on-year change?
Over the past year, LSB annual accounts receivable has changed by -$4.87 M (-7.24%)
What is LakeShore Biopharma Co Ltd quarterly accounts receivable?
The current quarterly accounts receivable of LSB is $75.51 M
What is the all time high quarterly accounts receivable for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high quarterly accounts receivable is $75.51 M
What is LakeShore Biopharma Co Ltd quarterly accounts receivable year-on-year change?
Over the past year, LSB quarterly accounts receivable has changed by $0.00 (0.00%)